When a commercial driver’s license (CDL) holder fails a Department of Transportation (DOT) drug test, the employer must act immediately.
A verified positive result can affect driver eligibility, dispatch operations, Drug and Alcohol Clearinghouse records, and the company’s federal safety compliance obligations.
For trucking companies, private fleets, and owner-operators, the correct response involves more than removing the driver from a route. Employers must follow federal testing procedures, provide required return-to-duty information, and maintain appropriate records.
Here are 10 steps employers should follow after receiving a verified positive DOT drug test result.
1. Confirm the Official DOT Drug Test Result
The first step is to distinguish an official DOT violation from a preliminary or unverified result.
DOT drug testing follows procedures established under 49 CFR Part 40. Laboratory findings are reviewed by a qualified Medical Review Officer (MRO), who determines whether the result is verified positive.
Employers should rely on the official result communicated through the regulated testing process.
Document the test date, type of test, MRO notification, date and time the result was received, and the person responsible for responding.
Do not treat rumors, preliminary laboratory findings, or informal messages as substitutes for the required verification process.
2. Immediately Remove the Driver From Safety-Sensitive Functions
Under 49 CFR § 40.23, an employer receiving a verified positive DOT drug test must immediately remove the employee from safety-sensitive duties. The employer cannot wait for written confirmation or the outcome of split-specimen testing.
For covered commercial drivers, safety-sensitive functions may include operating a commercial motor vehicle, vehicle inspection and servicing, certain loading activities, and other duties defined by federal regulations.
Notify dispatch and operational supervisors immediately.
If the driver is on the road, arrange a safe transition that does not require the prohibited driver to continue performing safety-sensitive duties.
Record when the driver was removed and who authorized the action.
3. Keep Employment Decisions Separate From DOT Requirements
A DOT drug testing violation and an employer’s disciplinary decision are different matters.
Federal regulations establish when a driver is prohibited from performing safety-sensitive work.
Company policy, employment agreements, collective bargaining provisions, and applicable law may determine whether the driver remains employed.
DOT regulations do not require employers to reinstate a driver merely because the driver later completes the return-to-duty process.
A company may choose not to return the employee to a safety-sensitive position, subject to applicable legal obligations.
However, terminating employment does not erase the DOT violation or eliminate required reporting responsibilities.
4. Provide Information About Substance Abuse Professionals
A driver who violates DOT drug and alcohol regulations must complete the required return-to-duty process before resuming covered safety-sensitive duties.
The process begins with an evaluation by a qualified Substance Abuse Professional (SAP).
Under 49 CFR § 40.287, employers must provide the employee with a list of readily available, acceptable SAPs, including names, addresses, and telephone numbers. Employers cannot charge the employee for preparing or providing this list.
The SAP evaluates the driver and prescribes appropriate education or treatment.
The driver must then satisfy the SAP’s requirements and receive a successful compliance determination before return-to-duty testing can proceed.
5. Verify FMCSA Clearinghouse Reporting
The FMCSA Drug and Alcohol Clearinghouse records specified drug and alcohol program violations involving CDL and commercial learner’s permit holders.
Employers must understand which information is reported by the MRO and which information must be reported by the employer or its designated consortium/third-party administrator (C/TPA).
FMCSA requires MROs to report verified positive drug test results within two business days of the applicable determination. Employers generally must report violations assigned to them by the close of the third business day after obtaining the information.
Do not assume the employer must duplicate a verified positive result already assigned to the MRO for reporting.
Instead, verify that each responsible party completes its required submission.
6. Understand Prohibited Status and CDL Downgrades
A driver with an unresolved DOT drug or alcohol program violation cannot perform covered safety-sensitive functions.
Under Clearinghouse II, which became enforceable November 18, 2024, state driver licensing agencies must remove commercial driving privileges from drivers in prohibited status. This can result in a CDL or CLP downgrade.
The driver must complete the applicable return-to-duty requirements and resolve any licensing restrictions before operating a commercial motor vehicle again.
Employers should verify the driver’s current Clearinghouse and licensing eligibility before assigning safety-sensitive work.
A valid-looking license card alone is not sufficient proof of eligibility.
7. Coordinate With Your DOT Drug Testing Provider
Many motor carriers rely on a C/TPA to administer portions of their DOT drug and alcohol testing program.
The provider may help coordinate SAP communications, return-to-duty testing, follow-up testing, and required documentation.
However, using a third-party administrator does not eliminate the employer’s responsibility for compliance.
Confirm who is responsible for each task and establish a documented communication process.
Owner-operators require particular attention.
FMCSA requires an owner-operator who employs themselves as a CDL driver to designate a C/TPA for applicable Clearinghouse reporting responsibilities.
8. Follow the Complete Return-to-Duty Process
A driver cannot simply take another drug test and return to work.
The DOT return-to-duty process generally requires:
- An initial SAP evaluation.
- Completion of prescribed education or treatment.
- A successful SAP follow-up evaluation.
- A DOT return-to-duty drug test with a verified negative result.
- Confirmation that the driver’s Clearinghouse and licensing status permit safety-sensitive work.
Under 49 CFR § 40.305, an employer may not return the driver to safety-sensitive functions before these requirements are satisfied.
A negative non-DOT drug test does not replace the required federal process.
9. Complete Required Follow-Up Testing
Returning to work does not necessarily end the driver’s testing obligations.
Under 49 CFR § 40.307, the SAP establishes a written follow-up testing plan specifying the number and frequency of tests. Federal rules require at least six unannounced follow-up tests during the first 12 months of safety-sensitive duty, with testing potentially extending for up to 60 months.
The employer must administer the applicable plan while the driver performs covered duties.
Follow-up tests are separate from random drug testing and must be conducted according to DOT requirements.
Employers should protect the confidentiality of testing schedules and results.
10. Review the Company’s Entire DOT Drug Testing Program
A failed test is an opportunity to identify weaknesses in the employer’s compliance procedures.
Review whether the company maintains:
- Required pre-employment testing procedures
- Random testing enrollment and selection records
- Annual Clearinghouse queries
- Required driver consent documentation
- Reasonable suspicion supervisor training
- Proper MRO and SAP communications
- Accurate return-to-duty and follow-up testing records
- Confidential drug and alcohol testing files
- Written procedures for removing prohibited drivers
If deficiencies are identified, correct them promptly.
What if the Driver Disputes the Positive Test?
Drivers may have rights to request split-specimen testing under DOT procedures.
The employer should refer questions concerning laboratory findings or medical explanations to the MRO and follow the applicable review process.
The employer must still remove the driver from safety-sensitive duties upon receiving the verified positive result. A pending split-specimen request does not authorize continued driving.
What if the Driver Is Terminated?
A terminated driver remains responsible for completing the applicable return-to-duty process before performing DOT-regulated safety-sensitive work for another employer.
The former employer must still satisfy any applicable reporting and recordkeeping requirements.
The violation is not erased simply because the employment relationship ends.
Frequently Asked Questions
Can a CDL driver work after failing a DOT drug test?
The driver cannot perform DOT safety-sensitive functions until the applicable return-to-duty requirements are completed. Non-safety-sensitive work may be possible depending on employer policy and applicable law.
Does every failed drug test go into the Clearinghouse?
The Clearinghouse records specified DOT drug and alcohol program violations. Non-DOT workplace testing results are not automatically Clearinghouse violations.
Can a driver return after one negative drug test?
No. A driver with a DOT violation must complete the required SAP and return-to-duty process.
Must an employer rehire a driver after SAP completion?
No. DOT rules establish eligibility to resume safety-sensitive duties, not a guarantee of employment.
Does the Clearinghouse apply to private fleets?
Yes, when the employer and driver are subject to the applicable FMCSA drug and alcohol testing requirements.
Get Help With DOT Drug Testing Compliance
A failed DOT drug test requires immediate action, accurate documentation, and careful coordination among employers, drivers, testing providers, and qualified SAPs.
MCS-150 Biennial Update Filing Services – Fmcsa.com provides private compliance education and assistance resources for motor carriers and businesses operating covered commercial vehicles.
Visit MCS-150 Biennial Update Filing Services – Fmcsa.com or call (800) 454-2522 for assistance understanding DOT drug testing and Clearinghouse requirements.
MCS-150 Biennial Update Filing Services – Fmcsa.com is a private compliance resource and is not the Federal Motor Carrier Safety Administration or an official government website.